Franklin Street Advisors’s Novelion Therapeutics Inc. Common Shares NVLN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-26,000
| Closed | -$18K | – | 161 |
|
|
2019
Q4 | $18K | Sell |
26,000
-20,000
| -43% | -$13.8K | ﹤0.01% | 153 |
|
|
2019
Q3 | $33K | Hold |
46,000
| – | – | ﹤0.01% | 155 |
|
|
2019
Q2 | $36K | Hold |
46,000
| – | – | ﹤0.01% | 157 |
|
|
2019
Q1 | $57K | Hold |
46,000
| – | – | 0.01% | 153 |
|
|
2018
Q4 | $39K | Buy |
46,000
+20,000
| +77% | +$17K | 0.01% | 144 |
|
|
2018
Q3 | $77K | Hold |
26,000
| – | – | 0.01% | 155 |
|
|
2018
Q2 | $96K | Hold |
26,000
| – | – | 0.01% | 154 |
|
|
2018
Q1 | $91K | Hold |
26,000
| – | – | 0.01% | 159 |
|
|
2017
Q4 | $81K | Buy |
26,000
+6,000
| +30% | +$18.7K | 0.01% | 161 |
|
|
2017
Q3 | $141K | Hold |
20,000
| – | – | 0.02% | 151 |
|
|
2017
Q2 | $185K | Sell |
20,000
-6,000
| -23% | -$55.5K | 0.03% | 142 |
|
|
2017
Q1 | $279K | Sell |
26,000
-10,000
| -28% | -$107K | 0.05% | 136 |
|
|
2016
Q4 | $303K | Buy |
+36,000
| New | +$303K | 0.05% | 147 |
|